"Pyrimidines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
| Descriptor ID |
D011743
|
| MeSH Number(s) |
D03.383.742
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pyrimidines".
Below are MeSH descriptors whose meaning is more specific than "Pyrimidines".
This graph shows the total number of publications written about "Pyrimidines" by people in this website by year, and whether "Pyrimidines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 4 | 4 |
| 2003 | 5 | 2 | 7 |
| 2004 | 7 | 3 | 10 |
| 2005 | 3 | 1 | 4 |
| 2006 | 4 | 2 | 6 |
| 2007 | 6 | 4 | 10 |
| 2008 | 9 | 2 | 11 |
| 2009 | 4 | 1 | 5 |
| 2010 | 7 | 2 | 9 |
| 2011 | 11 | 9 | 20 |
| 2012 | 4 | 5 | 9 |
| 2013 | 11 | 12 | 23 |
| 2014 | 11 | 7 | 18 |
| 2015 | 8 | 7 | 15 |
| 2016 | 19 | 8 | 27 |
| 2017 | 9 | 12 | 21 |
| 2018 | 20 | 8 | 28 |
| 2019 | 5 | 8 | 13 |
| 2020 | 6 | 11 | 17 |
| 2021 | 4 | 7 | 11 |
| 2022 | 1 | 11 | 12 |
| 2023 | 2 | 6 | 8 |
| 2024 | 8 | 11 | 19 |
| 2025 | 3 | 7 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pyrimidines" by people in Profiles.
-
Revisiting the Effect of Udenafil on Exercise Performance in Patients With Fontan Circulation: Results of a Post Hoc Analysis of the FUEL Trial. J Am Heart Assoc. 2025 Aug 19; 14(16):e041348.
-
PFKFB3 activates CAD to enhance de novo pyrimidine synthesis for cell growth. Cell Rep. 2025 Aug 26; 44(8):116071.
-
N-acetylaspartate from fat cells regulates postprandial body temperature. Nat Metab. 2025 Aug; 7(8):1524-1535.
-
Risdiplam treatment following onasemnogene abeparvovec in individuals with spinal muscular atrophy: a multicenter case series. BMC Neurol. 2025 Jul 07; 25(1):283.
-
Late Recurrence of Spindle Cell Sarcoma in Association with TPM3::NTRK1 Fusion. Int J Surg Pathol. 2025 Dec; 33(8):1709-1712.
-
Methylated Arginine Metabolites as Biomarkers for Clinical Status and Response to Type 5 Phosphodiesterase Inhibition in Patients With Fontan Circulation. J Am Heart Assoc. 2025 Apr; 14(7):e038061.
-
Impact of Co-mutations and Transcriptional Signatures in Non-Small Cell Lung Cancer Patients Treated with Adagrasib in the KRYSTAL-1 Trial. Clin Cancer Res. 2025 Mar 17; 31(6):1069-1081.
-
Peripheral neuropathy in the phase 3 ASPEN study of Bruton tyrosine kinase inhibitors for Waldenstr?m macroglobulinemia. Blood Adv. 2025 Feb 25; 9(4):722-728.
-
Zanubrutinib for the treatment of Bing-Neel syndrome. Br J Haematol. 2025 Apr; 206(4):1136-1140.
-
Preclinical efficacy of CDK7 inhibitor-based combinations against myeloproliferative neoplasms transformed to AML. Blood. 2025 02 06; 145(6):612-624.